- €7.20m
- €5.68m
- €14.78m
- 67
- 61
- 45
- 61
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8.86 | 9.08 | 10.1 | 12.5 | 14.8 |
Cost of Revenue | |||||
Gross Profit | 5.98 | 4.19 | 4.73 | 5.61 | 6.58 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 14.1 | 8.63 | 9.91 | 12.2 | 14.4 |
Operating Profit | -5.28 | 0.448 | 0.19 | 0.318 | 0.353 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.32 | 0.411 | 0.159 | 0.295 | 0.33 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.76 | 0.454 | 0.1 | 0.155 | 0.098 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.76 | 0.454 | 0.1 | 0.155 | 0.098 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.76 | 0.454 | 0.1 | 0.155 | 0.098 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.75 | 0.112 | 0.03 | 0.047 | 0.03 |
Dividends per Share |